APA (7th ed.) Citation

R, N., M, V., A, R., A, P., C, M., D, L., . . . X, D. (2023). Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis. Cancer communications (London, England), 43(5), 620. https://doi.org/10.1002/cac2.12409

Chicago Style (17th ed.) Citation

R, Navaridas, et al. "Transient and DNA-free in Vivo CRISPR/Cas9 Genome Editing for Flexible Modeling of Endometrial Carcinogenesis." Cancer Communications (London, England) 43, no. 5 (2023): 620. https://doi.org/10.1002/cac2.12409.

MLA (9th ed.) Citation

R, Navaridas, et al. "Transient and DNA-free in Vivo CRISPR/Cas9 Genome Editing for Flexible Modeling of Endometrial Carcinogenesis." Cancer Communications (London, England), vol. 43, no. 5, 2023, p. 620, https://doi.org/10.1002/cac2.12409.